MENU
+Compare
TARA
Stock ticker: NASDAQ
AS OF
Dec 26, 02:27 PM (EDT)
Price
$5.55
Change
+$0.06 (+1.09%)
Capitalization
294.19M

TARA Protara Therapeutics Forecast, Technical & Fundamental Analysis

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases... Show more

TARA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for TARA with price predictions
Dec 24, 2025

TARA's Stochastic Oscillator is remaining in oversold zone for 7 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TARA advanced for three days, in of 199 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for TARA moved out of overbought territory on December 01, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on December 05, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on TARA as a result. In of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for TARA turned negative on December 03, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

TARA moved below its 50-day moving average on December 15, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for TARA crossed bearishly below the 50-day moving average on December 18, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TARA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.224) is normal, around the industry mean (26.541). P/E Ratio (0.000) is within average values for comparable stocks, (51.479). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.873). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (311.015).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TARA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TARA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
TARA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

TARA is expected to report earnings to rise 32.90% to -41 cents per share on March 11

Protara Therapeutics TARA Stock Earnings Reports
Q4'25
Est.
$-0.41
Q3'25
Beat
by $0.07
Q2'25
Beat
by $0.05
Q1'25
Beat
by $0.18
Q4'24
Beat
by $0.11
The last earnings report on November 10 showed earnings per share of -31 cents, beating the estimate of -37 cents. With 235.08K shares outstanding, the current market capitalization sits at 294.19M.
A.I. Advisor
published General Information

General Information

a clinical-stage company, which engages in developing treatments for rare and specialty diseases with significant unmet needs.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
345 Park Avenue South
Phone
+1 646 844-0337
Employees
27
Web
http://www.protaratx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VOLVF32.400.50
+1.57%
Volvo AB
CKNHF52.66N/A
N/A
Clarkson Horace Plc
ZLDSF26.98N/A
N/A
ZALANDO SE
SKHRF0.57N/A
N/A
Stakeholder Gold Corp.
MSWV17.49N/A
N/A
Main Street Financial Services Corp.

TARA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TARA has been loosely correlated with SYRE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if TARA jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TARA
1D Price
Change %
TARA100%
+2.23%
SYRE - TARA
42%
Loosely correlated
-0.54%
AMLX - TARA
41%
Loosely correlated
+1.46%
RGNX - TARA
40%
Loosely correlated
+0.77%
IMTX - TARA
40%
Loosely correlated
+1.47%
DNLI - TARA
39%
Loosely correlated
+1.07%
More